These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 25533637)

  • 1. Genetic and functional diversity of propagating cells in glioblastoma.
    Piccirillo SGM; Colman S; Potter NE; van Delft FW; Lillis S; Carnicer MJ; Kearney L; Watts C; Greaves M
    Stem Cell Reports; 2015 Jan; 4(1):7-15. PubMed ID: 25533637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells.
    Wakimoto H; Mohapatra G; Kanai R; Curry WT; Yip S; Nitta M; Patel AP; Barnard ZR; Stemmer-Rachamimov AO; Louis DN; Martuza RL; Rabkin SD
    Neuro Oncol; 2012 Feb; 14(2):132-44. PubMed ID: 22067563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
    Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
    Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution.
    Kim H; Zheng S; Amini SS; Virk SM; Mikkelsen T; Brat DJ; Grimsby J; Sougnez C; Muller F; Hu J; Sloan AE; Cohen ML; Van Meir EG; Scarpace L; Laird PW; Weinstein JN; Lander ES; Gabriel S; Getz G; Meyerson M; Chin L; Barnholtz-Sloan JS; Verhaak RG
    Genome Res; 2015 Mar; 25(3):316-27. PubMed ID: 25650244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative genomic and genetic analysis of glioblastoma-derived brain tumor-initiating cells and their parent tumors.
    Davis B; Shen Y; Poon CC; Luchman HA; Stechishin OD; Pontifex CS; Wu W; Kelly JJ; Blough MD;
    Neuro Oncol; 2016 Mar; 18(3):350-60. PubMed ID: 26245525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of glioblastoma multiforme stem-like cells leads to downregulation of EGFR and EGFRvIII and decreased tumorigenic and stem-like cell potential.
    Stockhausen MT; Kristoffersen K; Stobbe L; Poulsen HS
    Cancer Biol Ther; 2014 Feb; 15(2):216-24. PubMed ID: 24525857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glioblastomas are composed of genetically divergent clones with distinct tumourigenic potential and variable stem cell-associated phenotypes.
    Stieber D; Golebiewska A; Evers L; Lenkiewicz E; Brons NH; Nicot N; Oudin A; Bougnaud S; Hertel F; Bjerkvig R; Vallar L; Barrett MT; Niclou SP
    Acta Neuropathol; 2014 Feb; 127(2):203-19. PubMed ID: 24154962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Notch signaling alters the phenotype of orthotopic tumors formed from glioblastoma multiforme neurosphere cells but does not hamper intracranial tumor growth regardless of endogene Notch pathway signature.
    Kristoffersen K; Nedergaard MK; Villingshøj M; Borup R; Broholm H; Kjær A; Poulsen HS; Stockhausen MT
    Cancer Biol Ther; 2014 Jul; 15(7):862-77. PubMed ID: 24755988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LGR5 promotes tumorigenicity and invasion of glioblastoma stem-like cells and is a potential therapeutic target for a subset of glioblastoma patients.
    Xie Y; Sundström A; Maturi NP; Tan EJ; Marinescu VD; Jarvius M; Tirfing M; Jin C; Chen L; Essand M; Swartling FJ; Nelander S; Jiang Y; Uhrbom L
    J Pathol; 2019 Feb; 247(2):228-240. PubMed ID: 30357839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-omics analysis of primary glioblastoma cell lines shows recapitulation of pivotal molecular features of parental tumors.
    Rosenberg S; Verreault M; Schmitt C; Guegan J; Guehennec J; Levasseur C; Marie Y; Bielle F; Mokhtari K; Hoang-Xuan K; Ligon K; Sanson M; Delattre JY; Idbaih A
    Neuro Oncol; 2017 Feb; 19(2):219-228. PubMed ID: 27571888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt/β-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells.
    Kim KH; Seol HJ; Kim EH; Rheey J; Jin HJ; Lee Y; Joo KM; Lee J; Nam DH
    Neuro Oncol; 2013 Feb; 15(2):161-71. PubMed ID: 23258844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LIN28A facilitates the transformation of human neural stem cells and promotes glioblastoma tumorigenesis through a pro-invasive genetic program.
    Mao XG; Hütt-Cabezas M; Orr BA; Weingart M; Taylor I; Rajan AK; Odia Y; Kahlert U; Maciaczyk J; Nikkhah G; Eberhart CG; Raabe EH
    Oncotarget; 2013 Jul; 4(7):1050-64. PubMed ID: 23846349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosomal Instability Affects the Tumorigenicity of Glioblastoma Tumor-Initiating Cells.
    Godek KM; Venere M; Wu Q; Mills KD; Hickey WF; Rich JN; Compton DA
    Cancer Discov; 2016 May; 6(5):532-45. PubMed ID: 27001151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells.
    Suvà ML; Rheinbay E; Gillespie SM; Patel AP; Wakimoto H; Rabkin SD; Riggi N; Chi AS; Cahill DP; Nahed BV; Curry WT; Martuza RL; Rivera MN; Rossetti N; Kasif S; Beik S; Kadri S; Tirosh I; Wortman I; Shalek AK; Rozenblatt-Rosen O; Regev A; Louis DN; Bernstein BE
    Cell; 2014 Apr; 157(3):580-94. PubMed ID: 24726434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-Specific requirement for BUB1B/BUBR1 in human brain tumor isolates and genetically transformed cells.
    Ding Y; Hubert CG; Herman J; Corrin P; Toledo CM; Skutt-Kakaria K; Vazquez J; Basom R; Zhang B; Risler JK; Pollard SM; Nam DH; Delrow JJ; Zhu J; Lee J; DeLuca J; Olson JM; Paddison PJ
    Cancer Discov; 2013 Feb; 3(2):198-211. PubMed ID: 23154965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transcript ENST00000444125 of lncRNA LINC01503 promotes cancer stem cell properties of glioblastoma cells via reducing FBXW1 mediated GLI2 degradation.
    Wei P; Jiang J; Xiao M; Zeng M; Liu X; Zhao B; Chen F
    Exp Cell Res; 2022 Mar; 412(1):113009. PubMed ID: 34990616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bmi1 regulates human glioblastoma stem cells through activation of differential gene networks in CD133+ brain tumor initiating cells.
    Vora P; Seyfrid M; Venugopal C; Qazi MA; Salim S; Isserlin R; Subapanditha M; O'Farrell E; Mahendram S; Singh M; Bakhshinyan D; Chokshi C; McFarlane N; Dvorkin-Gheva A; Brown KR; Murty N; Moffat J; Bader GD; Singh SK
    J Neurooncol; 2019 Jul; 143(3):417-428. PubMed ID: 31115870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3.
    Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J
    Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A molecular screening approach to identify and characterize inhibitors of glioblastoma stem cells.
    Visnyei K; Onodera H; Damoiseaux R; Saigusa K; Petrosyan S; De Vries D; Ferrari D; Saxe J; Panosyan EH; Masterman-Smith M; Mottahedeh J; Bradley KA; Huang J; Sabatti C; Nakano I; Kornblum HI
    Mol Cancer Ther; 2011 Oct; 10(10):1818-28. PubMed ID: 21859839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Casein kinase 2α regulates glioblastoma brain tumor-initiating cell growth through the β-catenin pathway.
    Nitta RT; Gholamin S; Feroze AH; Agarwal M; Cheshier SH; Mitra SS; Li G
    Oncogene; 2015 Jul; 34(28):3688-99. PubMed ID: 25241897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.